genetic variation

Pencil filling out Scantron test form
Biotech

AIRNA preps for clinical test with $155M series B

AIRNA's tech makes targeted adenosine-to-inosine edits in RNA, which the firm hopes can provide a functional cure for alpha-1 antitrypsin deficiency.
Darren Incorvaia Apr 1, 2025 7:00am
Eye

How new gene discoveries could guide precision medicine in MS

Oct 31, 2019 10:20am